To apply a free-running three-dimensional (3D) cine balanced steady state free precession (bSSFP) cardiovascular magnetic resonance (CMR) framework in combination with artificial intelligence (AI) segmentations to quantify time-resolved aortic displacement, diameter and diameter change. In this prospective study, we implemented a free-running 3D cine bSSFP sequence with scan time of approximately 4 min facilitated by pseudo-spiral Cartesian undersampling and compressed-sensing reconstruction. Automated segmentation of the aorta in all cardiac timeframes was applied through the use of nnU-Net. Dynamic 3D motion maps were created for three repeated scans per volunteer, leading to the detailed quantification of aortic motion, as well as the measurement and change in diameter of the ascending aorta. A total of 14 adult healthy volunteers (median age, 28 years (interquartile range [IQR]: 26.0-31.3), 6 females) were included. Automated segmentation compared to manual segmentation of the aorta test set showed a Dice score of 0.93 ± 0.02. The median (IQR) over all volunteers for the largest maximum and mean ascending aorta (AAo) displacement in the first scan was 13.0 (4.4) mm and 5.6 (2.4) mm, respectively. Peak mean diameter in the AAo was 25.9 (2.2) mm and peak mean diameter change was 1.4 (0.5) mm. The maximum individual variability over the three repeated scans of maximum and mean AAo displacement was 3.9 (1.6) mm and 2.2 (0.8) mm, respectively. The maximum individual variability of mean diameter and diameter change were 1.2 (0.5) mm and 0.9 (0.4) mm. A free-running 3D cine bSSFP CMR scan with a scan time of four minutes combined with an automated nnU-net segmentation consistently captured the aorta's cardiac motion-related 4D displacement, diameter, and diameter change.
Background Resveratrol, a dietary supplement that intervenes in cellular metabolism, has been shown to reduce aortic growth rate in a mouse model of Marfan syndrome (MFS), a condition associated in humans with life-threatening aortic complications, often preceded by aortic dilatation. The primary objective of this study was to investigate the effects of resveratrol on aortic growth rate in patients with MFS . Methods In this investigator-initiated, single-arm open-label multicentre trial, we analysed resveratrol treatment in adults aged 18–50 years with MFS. The primary endpoint was the change in estimated annual aortic growth at five predefined levels in the thoracic aorta after 1 year of resveratrol treatment, evaluated using a linear mixed model. Aortic diameters were measured by cardiac MRI at three time points to analyse the annual aortic expansion rate before and after initiation of treatment. Additionally, annual aortic growth was compared with growth in a previously conducted losartan randomised clinical trial. Results 898 patients were screened of which 19% (168/898) patients met the inclusion criteria. 36% (61/168) patients signed informed consent and 93% (57/61) aged 37±9 years, of which 28 males (49%) were included in the final analysis of the study. 46% (26/57) had undergone aortic root replacement prior to the study. Aortic root diameters remained stable after 1.2±0.3 years of resveratrol administration. A trend towards a decrease in estimated growth rate (mm/year) was observed in the aortic root (from 0.39±0.06 to −0.13±0.23, p=0.072), ascending aorta (from 0.40±0.05 to −0.01±0.18, p=0.072) and distal descending aorta (from 0.32±0.04 to 0.01±0.14, p=0.072). Conclusion Resveratrol treatment for 1 year may stabilise the aortic growth rate in adult patients with MFS. However, a subsequent randomised clinical trial with a longer follow-up duration and a larger study cohort is needed to establish an actual long-term beneficial effect of this dietary supplement in patients with MFS. Trial registration number NL66127.018.18.
Purpose: Aortic motion has direct impact on the mechanical stresses acting on the aorta. In aortic disease, increased stiffness of the aorta may lead to decreased aortic motion over time, which could be a predictor for aortic dissection or rupture. This study investigates the reproducibility of obtaining 3D displacement and diameter maps quantified using accelerated 3D cine MRI at 3 T.Methods: A noncontrast‐enhanced, free‐breathing 3D cine sequence based on balanced SSFP and pseudo‐spiral undersampling with high spatial isotropic resolution was developed (spatial/temporal resolution [1.6 mm]3/67 ms). The thoracic aorta of 14 healthy volunteers was prospectively scanned three times at 3 T: twice on the same day and a third time 2 weeks later. Aortic displacement was calculated using iterative closest point nonrigid registration of manual segmentations of the 3D aorta at end‐systole and mid‐diastole. Interexamination and interobserver regional analysis of mean displacement for five regions of interest was performed using Bland–Altman analysis. Additionally, a complementary voxel‐by‐voxel analysis was done, allowing a more local inspection of the method.Results: No significant differences were found in mean and maximum displacement for any of the regions of interest for the interexamination and interobserver analysis. The maximum displacement measured in the lower half of the ascending aorta was 11.0 ± 3.4 mm (range: 3.0–17.5 mm) for the first scan. The smallest detectable change in mean displacement in the lower half of the ascending aorta was 3 mm.Conclusion: Detailed 3D cine balanced SSFP at 3 T allows for reproducible quantification of systolic–diastolic mean aortic displacement within acceptable limits.
1 January 2026 in Quantitative Imaging in Medicine and Surgery
Four dimensional (4D) flow magnetic resonance imaging (MRI) enables both visualisation and quantification of hemodynamics in abdominal aortic aneurysms (AAAs). However, its clinical implementation remains limited due to time-consuming and cumbersome post-processing, as well as a lack of standardisation. While previous work has proposed automated solutions for thoracic and intracranial cases, applications in the abdominal region, particularly for AAAs, remain underexplored. The aim of this study was to develop an automated post-processing pipeline for 4D flow MRI in AAA patients, incorporating aneurysm identification, via automated segmentation, blood flow visualisation and hemodynamic parameter quantification. 4D flow MRI and three dimensional (3D) cine balanced steady state free precession (bSSFP) scans were acquired from 16 patients with an AAA in the same field of view and with an isotropic resolution of 1 mm. Using 5-fold cross-validation, an nnU-Net was trained to segment the aorta based on 3D cine bSSFP MRI. The automated post-processing pipeline was built using MATLAB. Wall shear stress (WSS) values were assessed within the extracted aneurysm. nnU-Net performance was assessed with the Dice-similarity coefficient (DSC), 95% percentile Hausdorff distance (HD95) and by calculating the Pearson correlation coefficients between WSS values obtained in the aneurysm based on segmentation with both methods. The resulting post-processing pipeline demonstrated robustness to anatomical variability, including tortuosity and intraluminal thrombus (ILT), both characteristic of AAA, and consistently produced output without user-interference. The nnU-Net performance was excellent for lumen segmentation and good for ILT segmentation, with DSCs of 0.93 (0.05) and 0.80 (0.26) respectively. The HD95 was 4.87 (8.59) mm and 6.04 (3.71) mm for respectively lumen and thrombus segmentation. Significant correlations (ρ =0.92 or higher) were found between WSS values derived using the manual and nnU-Net segmentations. An automated post-processing pipeline was developed specifically for 4D flow MRI in patients with AAA. The pipeline is robust for varying anatomies and may facilitate 4D flow MRI implementation in the clinical workflow.
Pulse wave velocity (PWV) is a key marker of aortic stiffness and cardiovascular risk, yet current methods typically offer only global or regional estimates and lack the possibility to measure local variations along the thoracic aorta. This study aimed to develop and evaluate a pipeline for assessing local aortic PWV using the flow–area (QA) method (PWVQA) by combining high-resolution 4D MRI techniques. A 3D cine balanced steady-state free precession (bSSFP) sequence was used to capture dynamic changes in aortic geometry, while 4D flow MRI measured time-resolved blood flow. The QA method was applied during the reflection-free early systolic phase. Scan–rescan reproducibility was assessed in six healthy volunteers, and feasibility was additionally explored in Marfan syndrome patients. The mean ± SD values of the Pearson correlation coefficients for per-slice maximum area, velocity, flow, and PWVQA were 0.99 ± 0.00, 0.82 ± 0.11, 0.96 ± 0.01, and 0.20 ± 0.35, respectively. The median (Q1–Q3) average PWVQA was 6.6 (5.4–9.4) m/s for scan 1 and 9.1 (6.7–11.3) m/s for scan 2 (p = 0.16) in healthy volunteers and 7.1 (6.9–8.0) m/s in Marfan patients. Combining 4D bSSFP and 4D flow MRI is technically feasible, but the derived PWVQA maps show high variability, particularly in the aortic root and descending aorta, requiring further optimization.